Polaris Inc. Beats Q1 2026 Earnings, Surpasses Revenue and EPS Estimates

PII
April 28, 2026

Polaris Inc. reported first‑quarter 2026 results, ending March 31, 2026, with adjusted diluted earnings per share of $0.13, a $0.55 beat over the consensus estimate of –$0.43. The company’s revenue reached $1.66 billion, topping the $1.63 billion estimate by $30 million.

The earnings beat was driven by a 14 % increase in Powersports sales, fueled by strong demand for Ranger models and commercial shipments, and by gains in the Off‑Road Vehicle and Snowmobile segments. Gross margin expanded 389 basis points to 20.5 %, and adjusted EBITDA margin rose 277 basis points, reflecting pricing power and cost discipline amid tariff headwinds.

Despite a $38 million tariff expense in the quarter, Polaris maintained margin growth, and the company reaffirmed its full‑year 2026 guidance: adjusted sales of $7.15 billion to $7.30 billion and adjusted EPS of $1.60 to $1.70. The guidance update signals management confidence in sustaining growth while acknowledging ongoing tariff and commodity cost pressures.

Management highlighted that the Indian Motorcycle separation had a neutral impact on the quarter’s results, and that the Marine segment experienced a decline in retail sales. CEO Mike Speetzen noted that the company is “entering 2026 from a position of strength” and that a relatively flat retail environment is expected, citing higher energy prices and geopolitical tensions as headwinds.

Analysts responded positively to the margin expansion and earnings surprise, with several upgrades to “Outperform” and price targets around $66. The market reaction reflected confidence in Polaris’s operational execution and its ability to navigate tariff and commodity challenges while pursuing market‑share gains.

The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.